STORY
4 days 6 outlets 10 reports running since 19.08

LATEST

Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story
finance.yahoo.com  ·  23.08.2026 08:23

HOW IT DEVELOPED

  1. Moderna Soars as Vaccine-Drug Combo Slows Recurrence of Melanoma finance.yahoo.com  ·  20.08 06:01
  2. Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations finance.yahoo.com  ·  19.08 23:58
  3. Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread aljazeera.com  ·  19.08 22:39
  4. mRNA Vaccine Stocks Rise on Moderna-Merck Success wsj.com  ·  19.08 20:29
  5. This Analyst Just Upgraded Moderna as MRNA Stock Skyrockets on Cancer Vaccine Results finance.yahoo.com  ·  19.08 19:10
  6. Moderna and Merck Just Made History With the First mRNA Cancer Vaccine to Succeed in a Phase 3 Trial. Here's What That Means for Investors. finance.yahoo.com  ·  19.08 18:54
  7. mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say arstechnica.com  ·  19.08 18:53
  8. Promising Results for mRNA Cancer Vaccine from Moderna and Merck time.com  ·  19.08 15:49
  9. Moderna share price doubles on melanoma vaccine trial success ft.com  ·  19.08 14:08